Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor editorial update to the study page.SummaryDifference0.0%

- Check20 days agoChange DetectedA line indicating NIH funding/contract information was added to the study's identifiers, clarifying the funding source and associated numbers.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the study documentation. This update affects only the metadata and does not change the presented study data or results.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision designation was updated from v3.6.3 to v3.6.4, signaling a small template or rendering update.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a new page version. This update appears to be a publisher-initiated edit reflecting corrections or minor updates to the page metadata or content without changing the core information presented to users.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0. This appears to be a software revision with no visible changes to the study content or metadata.SummaryDifference0.0%

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.